San Antonio, TX - SABCS 2008 San Antonio Breast Cancer Symposium: Stephen Johnston, Ph.D., consultant medical oncologist and reader in breast cancer medicine at the Royal Marsden NHS Foundation Trust in the United Kingdom addresses the Drugs in the Pipeline press conference on the study:Abstract #46. Lapatinib combined with letrozole vs. letrozole alone for front line postmenopausal hormone receptor positive (HR+) metastatic breast cancer (MBC): first results from the EGF30008 trialat the 2008 San Antonio Breast Cancer Symposium here today, Friday December 12, 2008. Over 8,000 Physicians, researchers and healthcare professionals from over 50 countries attended the meeting sponsored by American Association of Cancer Researchers (AACR) and the University of Texas, which features the latest research on Breast Cancer Treatment and Prevention. Date: Friday December 12, 2008 Photo by © SABCS/Todd Buchanan 2008 Technical Questions: email@example.com; Phone: 612-226-5154.
From 2008 SABCS General views and speakers